NCT06835244View on ClinicalTrials.gov

Diagnostic Performance of PET/CT-PSMA in Patients With Non-prostatic PSMA-expressing Neoplasms

Enrolling by invitationOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 17, 2021

Primary Completion Date

June 30, 2031

Study Completion Date

June 30, 2031

Conditions
PSMA Positive Tumors or Tumor TissuesCancer
Interventions
OTHER

68Ga-PSMA-11

All patients with non prostatic neoplasm expressing PSMA undergo 68\[Ga\]Ga-PSMA-11-PET/CT

Trial Locations (1)

40138

Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER